Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $9.29 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.62.
Market Cap
9.29T
Revenue
4.66T
Profits
187.2B
PE Ratio
49.62
Profit Margin
4.01%
Dividend Yield
0.38%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.09T | 0.43% | 1,943,143 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 628.65B | 0.41% | 4,638,165 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 439.59B | -0.53% | 3,780,381 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 364.06B | 0.85% | 3,316,932 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 327.94B | 1.92% | 11,427,137 | 66.57B |
| 6 | NVS | Novartis AG | 290.81B | -1.48% | 2,470,642 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 245.13B | -0.16% | 4,326,139 | 61.37B |
| 8 | AMGN | Amgen Inc. | 225.00B | 0.45% | 2,065,700 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 222.96B | -0.33% | 1,531,751 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 204.47B | -1.65% | 9,563,768 | 50.34B |
| 11 | ABT | Abbott Laboratories | 191.92B | 1.08% | 6,613,627 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 168.47B | 0.07% | 5,681,709 | 30.46B |
| 13 | PFE | Pfizer Inc. | 149.96B | -1.16% | 32,591,107 | 63.70B |
| 14 | DHR | Danaher Corporation | 144.67B | -0.80% | 3,038,426 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 141.76B | 0.01% | 3,141,659 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 133.25B | -0.74% | 1,046,927 | 12.59B |
| 17 | SYK | Stryker Corporation | 133.18B | -0.27% | 2,089,875 | 25.84B |
| 18 | BMY | Bristol-Myers Squibb Company | 130.12B | 0.14% | 7,509,596 | 49.19B |
| 19 | CVS | CVS Health Corporation | 121.14B | 1.30% | 8,299,058 | 412.65B |
| 20 | MDT | Medtronic plc | 116.18B | 0.09% | 6,232,076 | 36.36B |
| 21 | SNY | Sanofi | 104.29B | 0.34% | 2,930,555 | 55.89B |
| 22 | MCK | McKesson Corporation | 102.45B | -2.55% | 1,096,914 | 410.98B |
| 23 | GSK | GSK plc | 101.15B | -1.18% | 4,093,287 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 89.76B | 0.77% | 1,172,081 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.56B | 2.25% | 786,743 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.68B | 0.12% | 575,114 | 15.53B |
| 27 | BSX | Boston Scientific Corporation | 74.52B | 0.45% | 20,673,421 | 21.00B |
| 28 | CI | The Cigna Group | 73.30B | 1.29% | 1,532,033 | 282.38B |
| 29 | COR | Cencora, Inc. | 59.95B | -5.90% | 2,611,019 | 332.77B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 55.77B | -0.40% | 2,004,373 | 28.42B |
| 31 | ARGX | argenx SE | 54.93B | 1.30% | 172,617 | 5.32B |
| 32 | CAH | Cardinal Health, Inc. | 54.46B | -2.54% | 1,914,136 | 254.25B |
| 33 | EW | Edwards Lifesciences Corporation | 53.63B | -0.65% | 2,340,204 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 50.00B | 1.20% | 1,551,532 | 22.48B |
| 35 | HUM | Humana Inc. | 46.69B | 4.29% | 1,258,735 | 145.68B |
| 36 | MDLN | Medline Inc. | 46.67B | 1.31% | 6,632,303 | 29.94B |
| 37 | NTRA | Natera, Inc. | 45.54B | 1.04% | 1,579,734 | 2.71B |
| 38 | IDXX | IDEXX Laboratories, Inc. | 44.95B | -2.74% | 513,808 | 4.55B |
| 39 | RVMD | Revolution Medicines, Inc. | 43.99B | -0.14% | 1,175,785 | - |
| 40 | HLN | Haleon plc | 42.82B | -1.31% | 5,010,516 | 14.80B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 42.81B | 0.71% | 5,700,948 | 17.32B |
| 42 | A | Agilent Technologies, Inc. | 41.87B | -0.84% | 1,367,505 | 7.23B |
| 43 | WAT | Waters Corporation | 40.89B | 0.28% | 736,717 | 4.64B |
| 44 | ONC | BeOne Medicines AG | 40.82B | -0.06% | 314,887 | 6.13B |
| 45 | IQV | IQVIA Holdings Inc. | 39.79B | -0.87% | 854,907 | 16.98B |
| 46 | VEEV | Veeva Systems Inc. | 39.23B | 2.08% | 1,782,438 | 3.32B |
| 47 | ALC | Alcon Inc. | 35.26B | -2.35% | 2,945,279 | 10.86B |
| 48 | DXCM | DexCom, Inc. | 34.26B | 1.42% | 5,408,524 | 4.97B |
| 49 | RPRX | Royalty Pharma plc | 34.05B | 2.47% | 3,924,092 | 2.54B |
| 50 | CNC | Centene Corporation | 33.13B | 3.38% | 3,241,179 | 180.30B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 32.65B | -0.65% | 2,836,272 | 21.27B |
| 52 | RMD | ResMed Inc. | 32.60B | 0.52% | 1,403,347 | 5.65B |
| 53 | BIIB | Biogen Inc. | 30.86B | 2.44% | 789,365 | 10.03B |
| 54 | ZTS | Zoetis Inc. | 30.39B | -2.40% | 7,186,090 | 9.53B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.97B | 1.24% | 1,621,258 | 4.80B |
| 56 | ILMN | Illumina, Inc. | 29.13B | 0.04% | 1,256,001 | 4.49B |
| 57 | INSM | Insmed Incorporated | 28.89B | -0.22% | 1,562,756 | 1.14B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.82B | 0.09% | 140,915 | 4.13B |
| 59 | DGX | Quest Diagnostics Incorporated | 26.24B | 0.11% | 686,871 | 11.56B |
| 60 | LH | Labcorp Holdings Inc. | 26.23B | 0.33% | 365,952 | 14.35B |
| 61 | PHG | Koninklijke Philips N.V. | 26.16B | -0.92% | 700,700 | 20.18B |
| 62 | ROIV | Roivant Sciences Ltd. | 26.12B | 2.58% | 4,993,041 | 7.53M |
| 63 | MRNA | Moderna, Inc. | 25.42B | 5.12% | 6,581,998 | 2.23B |
| 64 | WST | West Pharmaceutical Services, Inc. | 24.79B | 0.26% | 423,677 | 3.33B |
| 65 | INCY | Incyte Corporation | 24.48B | -0.25% | 1,038,345 | 5.82B |
| 66 | BNTX | BioNTech SE | 23.30B | -0.06% | 476,343 | 3.03B |
| 67 | STE | STERIS plc | 23.07B | -0.68% | 648,289 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 22.16B | 0.01% | 1,224,215 | 1.18B |
| 69 | UTHR | United Therapeutics Corporation | 21.95B | -0.73% | 326,124 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 21.48B | 2.83% | 660,355 | 21.81B |
| 71 | GMAB | Genmab A/S | 18.77B | 1.85% | 3,516,915 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.67B | 0.68% | 2,732,652 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.49B | -1.11% | 13,605,541 | 14.74B |
| 74 | ASND | Ascendis Pharma A/S | 16.84B | 0.35% | 434,513 | 998.25M |
| 75 | MEDP | Medpace Holdings, Inc. | 16.66B | -1.41% | 310,378 | 2.78B |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.39B | 0.17% | 2,793,497 | 713.07M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 16.16B | 0.39% | 552,043 | 4.60B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.91B | -3.37% | 2,093,321 | 3.37B |
| 79 | COO | The Cooper Companies, Inc. | 14.96B | -0.12% | 2,952,500 | 4.23B |
| 80 | SOLV | Solventum Corporation | 14.52B | 1.41% | 833,980 | 8.31B |
| 81 | BAX | Baxter International Inc. | 13.93B | -2.39% | 6,881,036 | 11.47B |
| 82 | BMRN | BioMarin Pharmaceutical Inc. | 13.60B | 0.99% | 2,840,800 | 3.41B |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.58B | 0.84% | 1,166,500 | 4.00B |
| 84 | RVTY | Revvity, Inc. | 13.15B | 1.86% | 1,213,767 | 2.91B |
| 85 | ICLR | ICON Public Limited Company | 12.90B | 0.96% | 825,759 | 8.29B |
| 86 | PEN | Penumbra, Inc. | 12.86B | 0.09% | 230,042 | 1.50B |
| 87 | FMS | Fresenius Medical Care AG | 12.54B | -0.63% | 696,487 | 22.19B |
| 88 | EXEL | Exelixis, Inc. | 12.48B | -1.85% | 2,938,530 | 2.44B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.43B | 3.09% | 3,249,611 | 14.37B |
| 90 | SNN | Smith & Nephew plc | 12.42B | -0.57% | 890,199 | 6.30B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.39B | 0.17% | 285,533 | 1.28B |
| 92 | ALGN | Align Technology, Inc. | 12.36B | 0.61% | 658,393 | 4.14B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.32B | -2.23% | 1,119,602 | 669.50M |
| 94 | EHC | Encompass Health Corporation | 12.31B | -0.41% | 1,146,757 | 6.21B |
| 95 | CORT | Corcept Therapeutics Incorporated | 12.13B | 0.29% | 663,414 | 830.81M |
| 96 | SMMT | Summit Therapeutics Inc. | 12.05B | -0.13% | 3,676,377 | - |
| 97 | DVA | DaVita Inc. | 11.57B | 1.77% | 1,207,597 | 14.01B |
| 98 | HALO | Halozyme Therapeutics, Inc. | 11.55B | -0.81% | 3,647,497 | 1.66B |
| 99 | GMED | Globus Medical, Inc. | 11.50B | 0.61% | 1,086,004 | 3.14B |
| 100 | TECH | Bio-Techne Corporation | 11.26B | 0.11% | 2,358,991 | 1.22B |
| 101 | AXSM | Axsome Therapeutics, Inc. | 11.24B | -0.51% | 1,240,589 | 776.57M |
| 102 | ELAN | Elanco Animal Health Incorporated | 11.06B | -2.64% | 9,827,895 | 5.02B |
| 103 | GKOS | Glaukos Corporation | 11.00B | 2.54% | 758,878 | 612.84M |
| 104 | ABVX | ABIVAX Société Anonyme | 10.87B | -1.02% | 509,902 | 5.67M |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 10.79B | 4.22% | 484,961 | 7.46M |
| 106 | MOH | Molina Healthcare, Inc. | 10.73B | 5.92% | 833,199 | 42.47B |
| 107 | CYTK | Cytokinetics, Incorporated | 10.52B | -1.06% | 2,105,512 | 67.67M |
| 108 | ENSG | The Ensign Group, Inc. | 10.50B | 0.79% | 299,370 | 5.49B |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 10.47B | -0.48% | 2,217,545 | 3.50B |
| 110 | UHS | Universal Health Services, Inc. | 10.16B | 2.21% | 555,604 | 18.11B |
| 111 | APGE | Apogee Therapeutics, Inc. | 10.15B | -0.10% | 802,270 | - |
| 112 | HSIC | Henry Schein, Inc. | 10.11B | 1.75% | 1,041,521 | 13.60B |
| 113 | PODD | Insulet Corporation | 10.06B | 0.25% | 1,570,747 | 3.05B |
| 114 | TEM | Tempus AI, Inc. | 9.85B | -1.94% | 4,390,864 | 1.43B |
| 115 | KRYS | Krystal Biotech, Inc. | 9.85B | 1.78% | 161,923 | 440.48M |
| 116 | PTGX | Protagonist Therapeutics, Inc. | 9.84B | 2.51% | 417,199 | 281.99M |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 9.68B | 1.64% | 233,883 | 2.59B |
| 118 | KYMR | Kymera Therapeutics, Inc. | 9.48B | 4.02% | 960,271 | 105.00M |
| 119 | AVTR | Avantor, Inc. | 9.42B | 1.16% | 6,196,743 | 6.56B |
| 120 | IONS | Ionis Pharmaceuticals, Inc. | 9.39B | 2.00% | 2,011,025 | 874.09M |
| 121 | RGEN | Repligen Corporation | 9.35B | 0.56% | 833,920 | 785.10M |
| 122 | SYRE | Spyre Therapeutics, Inc. | 9.18B | 1.31% | 908,869 | - |
| 123 | OSCR | Oscar Health, Inc. | 9.13B | 5.86% | 6,644,325 | 15.32B |
| 124 | BRKR | Bruker Corporation | 9.03B | 3.95% | 2,205,144 | 3.50B |
| 125 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.96B | 0.12% | 2,583,838 | 42.16M |
| 126 | QGEN | Qiagen N.V. | 8.89B | 0.82% | 3,593,272 | 2.10B |
| 127 | PCVX | Vaxcyte, Inc. | 8.88B | 0.73% | 1,220,561 | - |
| 128 | HQY | HealthEquity, Inc. | 8.82B | -0.07% | 537,520 | 1.34B |
| 129 | IMVT | Immunovant, Inc. | 8.80B | 4.08% | 2,002,268 | - |
| 130 | ATR | AptarGroup, Inc. | 8.47B | -1.19% | 315,070 | 3.93B |
| 131 | ALKS | Alkermes plc | 8.44B | 2.17% | 1,315,645 | 1.67B |
| 132 | IBRX | ImmunityBio, Inc. | 8.20B | 1.84% | 5,339,992 | 165.79M |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.10B | 4.21% | 574,302 | 239.92M |
| 134 | TWST | Twist Bioscience Corporation | 7.85B | 1.70% | 1,605,547 | 431.80M |
| 135 | TXG | 10x Genomics, Inc. | 7.52B | -1.25% | 3,743,775 | 616.91M |
| 136 | PACS | PACS Group, Inc. | 7.20B | 1.16% | 563,467 | 5.55B |
| 137 | ORKA | Oruka Therapeutics, Inc. | 7.11B | 2.60% | 945,212 | - |
| 138 | LQDA | Liquidia Corporation | 7.05B | -10.52% | 3,990,741 | 450.91M |
| 139 | CHE | Chemed Corporation | 7.04B | 0.72% | 139,869 | 2.60B |
| 140 | BLTE | Belite Bio, Inc | 7.04B | 0.77% | 158,085 | - |
| 141 | TGTX | TG Therapeutics, Inc. | 7.02B | -0.80% | 2,017,943 | 799.54M |
| 142 | HIMS | Hims & Hers Health, Inc. | 6.99B | -1.77% | 16,906,985 | 2.58B |
| 143 | HNGE | Hinge Health, Inc. | 6.97B | -3.02% | 1,369,610 | 720.06M |
| 144 | GRFS | Grifols, S.A. | 6.96B | -0.75% | 237,581 | 8.48B |
| 145 | CGON | CG Oncology, Inc. | 6.82B | -0.05% | 766,100 | 6.23M |
| 146 | COGT | Cogent Biosciences, Inc. | 6.77B | 0.72% | 2,977,657 | - |
| 147 | LNTH | Lantheus Holdings, Inc. | 6.57B | 0.05% | 1,487,802 | 1.56B |
| 148 | SRRK | Scholar Rock Holding Corporation | 6.55B | 3.36% | 899,243 | - |
| 149 | ERAS | Erasca, Inc. | 6.50B | 1.47% | 3,647,520 | - |
| 150 | MIRM | Mirum Pharmaceuticals, Inc. | 6.43B | 0.75% | 649,458 | 618.07M |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 6.32B | 3.23% | 778,184 | 7.50M |
| 152 | CAI | Caris Life Sciences, Inc. | 6.29B | -3.80% | 4,423,150 | 989.61M |
| 153 | DNTH | Dianthus Therapeutics, Inc. | 6.29B | 3.61% | 653,981 | 1.90M |
| 154 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.10B | 0.45% | 572,329 | 840.85M |
| 155 | PTCT | PTC Therapeutics, Inc. | 6.06B | -1.44% | 975,967 | 1.01B |
| 156 | RDNT | RadNet, Inc. | 6.06B | 0.80% | 637,367 | 2.27B |
| 157 | BLCO | Bausch + Lomb Corporation | 5.99B | -0.65% | 549,514 | 5.32B |
| 158 | TVTX | Travere Therapeutics, Inc. | 5.86B | 3.24% | 1,040,993 | 591.33M |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 5.85B | 1.57% | 381,522 | 290.54M |
| 160 | MMED | MiniMed Group, Inc. | 5.81B | 4.65% | 1,311,937 | 3.10B |
| 161 | STVN | Stevanato Group S.p.A. | 5.80B | 0.95% | 622,253 | 1.40B |
| 162 | TFX | Teleflex Incorporated | 5.78B | 2.08% | 515,663 | 2.25B |
| 163 | DFTX | Definium Therapeutics, Inc. | 5.75B | 4.60% | 7,635,665 | - |
| 164 | AMRX | Amneal Pharmaceuticals, Inc. | 5.64B | 3.27% | 3,322,802 | 3.12B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.45B | 0.10% | 868,374 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.39B | -1.15% | 2,670,983 | 1.22B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.22B | -0.15% | 742,824 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.07B | 0.14% | 1,409,509 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.89B | -2.02% | 1,779,056 | - |
| 170 | PBLS | Parabilis Medicines, Inc. | 4.76B | 2.58% | 217,305 | - |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.73B | -1.69% | 995,785 | - |
| 172 | WAY | Waystar Holding Corp. | 4.71B | 0.99% | 3,325,158 | 1.21B |
| 173 | LFST | LifeStance Health Group, Inc. | 4.67B | 6.35% | 6,377,349 | 1.58B |
| 174 | NVST | Envista Holdings Corporation | 4.61B | 0.67% | 2,527,799 | 2.86B |
| 175 | BLLN | BillionToOne, Inc. | 4.60B | -0.50% | 522,860 | 397.41M |
| 176 | INDV | Indivior Pharmaceuticals, Inc. | 4.57B | 0.78% | 2,570,130 | 1.33B |
| 177 | MANE | Veradermics, Incorporated | 4.56B | 0.09% | 1,359,693 | - |
| 178 | CELC | Celcuity Inc. | 4.49B | 4.51% | 795,200 | - |
| 179 | ICUI | ICU Medical, Inc. | 4.48B | -1.50% | 310,695 | 2.16B |
| 180 | DOCS | Doximity, Inc. | 4.45B | -4.29% | 5,222,416 | 655.57M |
| 181 | LIVN | LivaNova PLC | 4.45B | 2.80% | 978,371 | 1.47B |
| 182 | CON | Concentra Group Holdings Parent, Inc. | 4.40B | 4.57% | 1,344,743 | 2.29B |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.40B | 0.40% | 1,610,967 | 10.35M |
| 184 | TNGX | Tango Therapeutics, Inc. | 4.31B | -2.89% | 2,433,848 | 53.81M |
| 185 | ITGR | Integer Holdings Corporation | 4.25B | 0.03% | 953,951 | 1.84B |
| 186 | ELVN | Enliven Therapeutics, Inc. | 4.24B | -1.46% | 1,010,869 | - |
| 187 | HAE | Haemonetics Corporation | 4.16B | 4.72% | 822,991 | 1.35B |
| 188 | IRTC | iRhythm Holdings, Inc. | 4.13B | 2.86% | 981,901 | 825.34M |
| 189 | TLX | Telix Pharmaceuticals Limited | 4.06B | -0.25% | 76,393 | 803.79M |
| 190 | DNLI | Denali Therapeutics Inc. | 4.04B | 2.35% | 1,442,227 | 3.60M |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 4.03B | -0.55% | 1,706,720 | 308.08M |
| 192 | LEGN | Legend Biotech Corporation | 3.99B | -5.41% | 3,689,162 | 1.27B |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.97B | 0.65% | 1,473,597 | - |
| 194 | GPCR | Structure Therapeutics Inc. | 3.84B | 3.41% | 1,517,877 | - |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.69B | 0.77% | 943,850 | 117.00M |
| 196 | VCYT | Veracyte, Inc. | 3.59B | -3.73% | 873,977 | 561.90M |
| 197 | OGN | Organon & Co. | 3.59B | 0.07% | 5,664,318 | 6.13B |
| 198 | OPCH | Option Care Health, Inc. | 3.57B | -1.00% | 1,747,551 | 5.69B |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.57B | 0.33% | 508,802 | 234.13M |
| 200 | CLDX | Celldex Therapeutics, Inc. | 3.52B | 1.22% | 1,594,517 | 158.00K |
| 201 | NHC | National HealthCare Corporation | 3.47B | 2.28% | 144,127 | 1.56B |
| 202 | NAMS | NewAmsterdam Pharma Company N.V. | 3.33B | 0.76% | 1,627,483 | 7.12M |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.30B | 0.19% | 1,317,972 | 463.98M |
| 204 | ALMS | Alumis Inc. | 3.26B | 0.71% | 991,768 | 8.40M |
| 205 | MBX | MBX Biosciences, Inc. | 3.23B | 1.45% | 331,425 | - |
| 206 | IMNM | Immunome, Inc. | 3.18B | 6.63% | 1,561,203 | 4.02M |
| 207 | ABCL | AbCellera Biologics Inc. | 3.17B | 6.10% | 14,854,457 | 66.17M |
| 208 | QURE | uniQure N.V. | 3.13B | 0.29% | 737,520 | 18.67M |
| 209 | WRBY | Warby Parker Inc. | 3.13B | 1.12% | 2,452,230 | 911.61M |
| 210 | BKD | Brookdale Senior Living Inc. | 3.10B | 3.43% | 7,613,243 | 2.93B |
| 211 | IRON | Disc Medicine, Inc. | 3.09B | -0.76% | 263,328 | - |
| 212 | PLSE | Pulse Biosciences, Inc. | 3.09B | -2.43% | 334,785 | 1.19M |
| 213 | GRAL | GRAIL, Inc. | 3.08B | -8.66% | 564,992 | 165.26M |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 3.07B | 0.80% | 1,076,670 | 606.33M |
| 215 | IOVA | Iovance Biotherapeutics, Inc. | 3.05B | 3.85% | 13,455,825 | 324.97M |
| 216 | TMDX | TransMedics Group, Inc. | 3.02B | -2.62% | 682,265 | 668.47M |
| 217 | ACHC | Acadia Healthcare Company, Inc. | 2.95B | 1.93% | 1,452,577 | 3.37B |
| 218 | ZLAB | Zai Lab Limited | 2.86B | -1.96% | 2,182,416 | 449.61M |
| 219 | ALHC | Alignment Healthcare, Inc. | 2.80B | 2.42% | 6,026,268 | 4.58B |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.78B | 2.11% | 699,729 | 830.44M |
| 221 | NRIX | Nurix Therapeutics, Inc. | 2.76B | 2.58% | 991,893 | 36.77M |
| 222 | PRVA | Privia Health Group, Inc. | 2.75B | -2.00% | 1,694,685 | 2.36B |
| 223 | KOD | Kodiak Sciences Inc. | 2.71B | 3.09% | 382,916 | - |
| 224 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.71B | 2.42% | 3,865,522 | 940.61M |
| 225 | ATAI | AtaiBeckley Inc. | 2.68B | 0.28% | 3,865,607 | 4.47M |
| 226 | AXGN | Axogen, Inc. | 2.67B | 2.45% | 716,440 | 251.17M |
| 227 | BEAM | Beam Therapeutics Inc. | 2.67B | -0.52% | 1,553,882 | 156.04M |
| 228 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | -0.37% | 1,544,755 | 717.00M |
| 229 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.60B | -1.18% | 1,560,161 | -665.00K |
| 230 | VRDN | Viridian Therapeutics, Inc. | 2.59B | -0.39% | 1,578,262 | 71.13M |
| 231 | HTFL | HeartFlow, Inc. | 2.57B | 1.05% | 1,080,959 | 191.42M |
| 232 | NKTR | Nektar Therapeutics | 2.57B | 0.70% | 599,721 | 55.63M |
| 233 | PHVS | Pharvaris N.V. | 2.56B | 5.93% | 1,273,185 | - |
| 234 | TRVI | Trevi Therapeutics, Inc. | 2.53B | -0.39% | 1,226,980 | - |
| 235 | BFLY | Butterfly Network, Inc. | 2.52B | 0.85% | 3,901,301 | 112.14M |
| 236 | RGC | Regencell Bioscience Holdings Limited | 2.51B | 0.80% | 187,331 | - |
| 237 | NEOG | Neogen Corporation | 2.50B | -0.26% | 1,435,265 | 870.40M |
| 238 | COAG | Hemab Therapeutics Holdings, Inc. | 2.50B | 3.36% | 278,315 | - |
| 239 | UFPT | UFP Technologies, Inc. | 2.50B | 0.17% | 132,298 | 631.64M |
| 240 | PBH | Prestige Consumer Healthcare Inc. | 2.48B | -2.48% | 645,793 | 1.10B |
| 241 | WGS | GeneDx Holdings Corp. | 2.46B | 0.80% | 506,581 | 454.43M |
| 242 | PGEN | Precigen, Inc. | 2.45B | -0.15% | 4,424,089 | 85.72M |
| 243 | CDNA | CareDx, Inc. | 2.45B | 0.17% | 912,567 | 458.09M |
| 244 | GRDN | Guardian Pharmacy Services, Inc. | 2.44B | -2.23% | 383,780 | 1.46B |
| 245 | CLOV | Clover Health Investments, Corp. | 2.41B | 3.42% | 4,759,032 | 2.48B |
| 246 | KLRA | Kailera Therapeutics, Inc. | 2.41B | -1.48% | 246,445 | - |
| 247 | URGN | UroGen Pharma Ltd. | 2.40B | 4.01% | 1,701,235 | 188.73M |
| 248 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | -1.02% | 1,396,596 | - |
| 249 | SLS | SELLAS Life Sciences Group, Inc. | 2.38B | 6.52% | 7,796,833 | - |
| 250 | BHC | Bausch Health Companies Inc. | 2.32B | -0.48% | 2,195,005 | 10.85B |
| 251 | HRMY | Harmony Biosciences Holdings, Inc. | 2.32B | 0.63% | 705,474 | 959.90M |
| 252 | ALMR | Alamar Biosciences, Inc. | 2.30B | -9.43% | 558,186 | 100.42M |
| 253 | VCEL | Vericel Corporation | 2.29B | 0.86% | 272,865 | 306.30M |
| 254 | RAPP | Rapport Therapeutics, Inc. | 2.29B | -2.23% | 316,883 | 20.00M |
| 255 | XRAY | DENTSPLY SIRONA Inc. | 2.27B | -1.72% | 7,606,928 | 3.64B |
| 256 | NUVB | Nuvation Bio Inc. | 2.25B | 0.78% | 2,592,651 | 169.90M |
| 257 | ESTA | Establishment Labs Holdings Inc. | 2.25B | 1.75% | 615,007 | 245.82M |
| 258 | SEPN | Septerna, Inc. | 2.25B | 0.90% | 1,261,317 | 98.88M |
| 259 | OCUL | Ocular Therapeutix, Inc. | 2.25B | 4.82% | 4,006,250 | 52.06M |
| 260 | PVLA | Palvella Therapeutics, Inc. | 2.23B | 0.36% | 166,680 | - |
| 261 | ATRC | AtriCure, Inc. | 2.22B | 1.42% | 473,250 | 569.62M |
| 262 | MESO | Mesoblast Limited | 2.21B | -0.83% | 211,810 | 65.38M |
| 263 | ADMA | ADMA Biologics, Inc. | 2.19B | -1.31% | 1,919,177 | 512.28M |
| 264 | BHVN | Biohaven Ltd. | 2.17B | -0.69% | 2,139,022 | - |
| 265 | VERA | Vera Therapeutics, Inc. | 2.16B | -0.99% | 1,473,177 | - |
| 266 | ADUS | Addus HomeCare Corporation | 2.16B | 1.00% | 225,835 | 1.48B |
| 267 | STOK | Stoke Therapeutics, Inc. | 2.13B | 0.03% | 1,078,372 | 27.59M |
| 268 | HCM | HUTCHMED (China) Limited | 2.12B | -1.76% | 34,284 | 549.12M |
| 269 | NEO | NeoGenomics, Inc. | 2.11B | -0.67% | 1,047,450 | 766.30M |
| 270 | MD | Pediatrix Medical Group, Inc. | 2.10B | 1.38% | 630,994 | 1.95B |
| 271 | TSHA | Taysha Gene Therapies, Inc. | 2.09B | -4.12% | 4,405,408 | 5.49M |
| 272 | GHRS | GH Research PLC | 2.08B | 3.99% | 1,132,489 | - |
| 273 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 0.52% | 854,378 | 311.51M |
| 274 | NVCR | NovoCure Limited | 2.05B | -0.40% | 1,183,337 | 699.19M |
| 275 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | 4.65% | 1,692,893 | 98.34M |
| 276 | KARD | Kardigan, Inc. | 2.04B | -1.27% | 242,462 | - |
| 277 | NBTX | Nanobiotix S.A. | 2.02B | 1.86% | 180,518 | 38.27M |
| 278 | SGRY | Surgery Partners, Inc. | 1.99B | 2.13% | 3,868,742 | 3.37B |
| 279 | ZBIO | Zenas BioPharma, Inc. | 1.98B | -3.55% | 461,554 | 10.00M |
| 280 | AVAH | Aveanna Healthcare Holdings Inc. | 1.97B | 1.12% | 3,817,603 | 2.52B |
| 281 | PGNY | Progyny, Inc. | 1.95B | -4.33% | 2,151,429 | 1.31B |
| 282 | SRPT | Sarepta Therapeutics, Inc. | 1.94B | 0.88% | 2,369,421 | 1.97B |
| 283 | GENB | Generate Biomedicines, Inc. | 1.94B | 5.75% | 749,562 | 26.48M |
| 284 | CMPS | COMPASS Pathways plc | 1.92B | 6.28% | 4,086,007 | - |
| 285 | DMRA | Damora Therapeutics, Inc. | 1.91B | 2.11% | 314,349 | - |
| 286 | LMAT | LeMaitre Vascular, Inc. | 1.88B | -0.86% | 351,518 | 262.43M |
| 287 | FBRX | Forte Biosciences, Inc. | 1.88B | -0.12% | 1,930,306 | - |
| 288 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -2.78% | 375,124 | 1.13B |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.85B | 0.33% | 478,582 | 481.07M |
| 290 | ASTH | Astrana Health, Inc. | 1.83B | 3.80% | 589,362 | 3.84B |
| 291 | IMCR | Immunocore Holdings plc | 1.79B | 1.64% | 352,887 | 430.78M |
| 292 | ZYME | Zymeworks Inc. | 1.77B | 2.51% | 531,133 | 37.13M |
| 293 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | -2.41% | 1,069,376 | 252.25M |
| 294 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | -1.79% | 10,305,021 | 54.86M |
| 295 | PRGO | Perrigo Company plc | 1.76B | -1.25% | 2,361,990 | 4.14B |
| 296 | TRLV | Trulieve Cannabis Corp. | 1.75B | -2.04% | 435,661 | 1.14B |
| 297 | FTRE | Fortrea Holdings Inc. | 1.74B | -6.10% | 1,947,251 | 2.68B |
| 298 | XNCR | Xencor, Inc. | 1.72B | 4.89% | 1,967,413 | 104.97M |
| 299 | AAPG | Ascentage Pharma Group International | 1.71B | -0.05% | 2,625 | 82.08M |
| 300 | BLFS | BioLife Solutions, Inc. | 1.71B | 0.43% | 348,528 | 106.69M |
| 301 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 0.58% | 2,041,967 | 59.51M |
| 302 | OMCL | Omnicell, Inc. | 1.69B | 0.73% | 742,174 | 1.25B |
| 303 | ANAB | AnaptysBio, Inc. | 1.69B | -1.50% | 381,729 | 232.39M |
| 304 | INSP | Inspire Medical Systems, Inc. | 1.68B | -1.44% | 571,443 | 898.74M |
| 305 | BRVE | Braveheart Bio, Inc. | 1.68B | 4.56% | 634,087 | - |
| 306 | AVLN | Avalyn Pharma Inc. | 1.66B | 5.41% | 378,235 | - |
| 307 | KMTS | Kestra Medical Technologies, Ltd. | 1.64B | 0.36% | 406,117 | 95.13M |
| 308 | TNDM | Tandem Diabetes Care, Inc. | 1.63B | - | 1,750,128 | 1.04B |
| 309 | ABSI | Absci Corporation | 1.63B | 0.96% | 4,038,507 | 1.56M |
| 310 | BCAX | Bicara Therapeutics Inc. | 1.63B | 3.66% | 810,258 | - |
| 311 | ANIP | ANI Pharmaceuticals, Inc. | 1.61B | 0.78% | 469,443 | 978.38M |
| 312 | TRAX | First Tracks Biotherapeutics, Inc. | 1.61B | -1.33% | 456,928 | - |
| 313 | ARDT | Ardent Health, Inc. | 1.57B | 1.19% | 297,178 | 6.41B |
| 314 | XERS | Xeris Biopharma Holdings, Inc. | 1.55B | 1.19% | 1,842,049 | 335.41M |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.53B | 0.81% | 441,662 | 20.00M |
| 316 | PSNL | Personalis, Inc. | 1.52B | 1.36% | 1,549,806 | 69.67M |
| 317 | VIR | Vir Biotechnology, Inc. | 1.52B | 0.34% | 909,271 | 303.23M |
| 318 | TYRA | Tyra Biosciences, Inc. | 1.51B | 0.48% | 478,321 | - |
| 319 | INVA | Innoviva, Inc. | 1.50B | 0.29% | 595,858 | 440.00M |
| 320 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.50B | -0.52% | 1,770,967 | 208.78M |
| 321 | ATEC | Alphatec Holdings, Inc. | 1.49B | 2.77% | 1,947,880 | 815.05M |
| 322 | CNMD | CONMED Corporation | 1.48B | -0.20% | 396,366 | 1.37B |
| 323 | JBIO | Jade Biosciences, Inc. | 1.48B | 3.85% | 713,779 | - |
| 324 | HROW | Harrow, Inc. | 1.48B | -0.15% | 804,490 | 275.59M |
| 325 | AZTA | Azenta, Inc. | 1.47B | 0.42% | 527,888 | 613.81M |
| 326 | MLTX | MoonLake Immunotherapeutics | 1.47B | 3.86% | 2,913,599 | - |
| 327 | AVBP | ArriVent BioPharma, Inc. | 1.47B | 0.22% | 295,752 | - |
| 328 | LBRX | LB Pharmaceuticals Inc | 1.46B | 0.11% | 355,979 | - |
| 329 | OMDA | Omada Health, Inc. | 1.46B | -0.71% | 1,677,110 | 309.76M |
| 330 | SVRA | Savara Inc. | 1.45B | 2.33% | 1,174,983 | - |
| 331 | AGL | agilon health, inc. | 1.45B | -0.15% | 366,993 | 5.92B |
| 332 | INBX | Inhibrx Biosciences, Inc. | 1.44B | 6.47% | 158,558 | 1.30M |
| 333 | ALVO | Alvotech | 1.43B | 5.53% | 920,574 | 562.04M |
| 334 | REPL | Replimune Group, Inc. | 1.43B | 11.65% | 8,272,476 | - |
| 335 | HCSG | Healthcare Services Group, Inc. | 1.43B | -0.76% | 866,659 | 1.86B |
| 336 | ORIC | ORIC Pharmaceuticals, Inc. | 1.43B | 0.15% | 1,147,117 | - |
| 337 | ENOV | Enovis Corporation | 1.42B | 0.37% | 1,143,329 | 2.30B |
| 338 | INNV | InnovAge Holding Corp. | 1.42B | 1.96% | 197,672 | 949.17M |
| 339 | AORT | Artivion, Inc. | 1.40B | 0.88% | 758,936 | 471.47M |
| 340 | SDGR | Schrödinger, Inc. | 1.39B | -0.11% | 1,313,463 | 259.04M |
| 341 | PAHC | Phibro Animal Health Corporation | 1.37B | -0.73% | 180,631 | 1.50B |
| 342 | GLUE | Monte Rosa Therapeutics, Inc. | 1.36B | 1.21% | 780,867 | 28.73M |
| 343 | IART | Integra LifeSciences Holdings Corporation | 1.35B | 0.06% | 469,495 | 1.65B |
| 344 | PNTG | The Pennant Group, Inc. | 1.34B | 0.55% | 398,978 | 1.10B |
| 345 | IMTX | Immatics N.V. | 1.33B | -0.41% | 294,257 | 43.00M |
| 346 | AKTS | Aktis Oncology, Inc. | 1.33B | -3.11% | 213,754 | 8.28M |
| 347 | VOR | Vor Biopharma Inc. | 1.32B | -5.30% | 992,203 | - |
| 348 | NVAX | Novavax, Inc. | 1.31B | 0.13% | 2,541,803 | 413.80M |
| 349 | FRNM | Freenome, Inc. | 1.30B | -3.67% | 1,407,398 | 34.24M |
| 350 | DRTS | Alpha Tau Medical Ltd. | 1.28B | -2.80% | 500,608 | - |
| 351 | SPTX | Seaport Therapeutics, Inc. | 1.27B | 1.88% | 246,283 | - |
| 352 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | 2.17% | 1,025,098 | - |
| 353 | STAA | STAAR Surgical Company | 1.27B | 1.88% | 1,338,637 | 339.59M |
| 354 | CGEM | Cullinan Therapeutics, Inc. | 1.26B | -0.15% | 675,991 | - |
| 355 | AHG | Akso Health Group | 1.26B | 5.72% | 945 | 13.83M |
| 356 | AMN | AMN Healthcare Services, Inc. | 1.26B | -2.02% | 947,001 | 3.43B |
| 357 | MNKD | MannKind Corporation | 1.24B | 0.26% | 3,055,992 | 393.63M |
| 358 | LTGO | Latigo Biotherapeutics, Inc. | 1.23B | 4.62% | 208,107 | - |
| 359 | GDRX | GoodRx Holdings, Inc. | 1.22B | -5.53% | 1,599,972 | 785.23M |
| 360 | USPH | U.S. Physical Therapy, Inc. | 1.22B | 0.34% | 127,481 | 804.27M |
| 361 | CERT | Certara, Inc. | 1.22B | -1.48% | 3,340,762 | 421.75M |
| 362 | TDOC | Teladoc Health, Inc. | 1.22B | -1.47% | 4,092,323 | 2.49B |
| 363 | PRCT | PROCEPT BioRobotics Corporation | 1.22B | -7.16% | 1,156,178 | 337.34M |
| 364 | OBX | Obsidian Therapeutics, Inc. | 1.21B | -14.89% | 111,534 | - |
| 365 | MGTX | MeiraGTx Holdings plc | 1.20B | -0.69% | 274,579 | 79.76M |
| 366 | NUTX | Nutex Health Inc. | 1.18B | 3.60% | 174,247 | 846.72M |
| 367 | CRON | Cronos Group Inc. | 1.17B | 2.92% | 2,051,509 | 179.09M |
| 368 | BVS | Bioventus Inc. | 1.17B | 0.47% | 536,486 | 581.85M |
| 369 | EYPT | EyePoint, Inc. | 1.17B | 3.68% | 2,261,368 | 2.79M |
| 370 | ETON | Eton Pharmaceuticals, Inc. | 1.14B | -1.12% | 550,375 | 86.93M |
| 371 | ANRO | Alto Neuroscience, Inc. | 1.13B | 1.39% | 278,061 | - |
| 372 | SANA | Sana Biotechnology, Inc. | 1.13B | -0.53% | 1,819,576 | - |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | 0.60% | 749,473 | 1.03B |
| 374 | IVA | Inventiva S.A. | 1.12B | -1.06% | 414,790 | 7.94M |
| 375 | IRMD | IRADIMED CORPORATION | 1.12B | -1.73% | 222,667 | 86.34M |
| 376 | APMD | Apnimed, Inc. | 1.06B | 7.14% | 273,833 | 120.15M |
| 377 | AVTX | Avalo Therapeutics, Inc. | 1.05B | 0.41% | 317,247 | 59.00K |
| 378 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.05B | -3.29% | 2,569,147 | 41.47M |
| 379 | OPK | OPKO Health, Inc. | 1.04B | - | 1,834,586 | 587.90M |
| 380 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | 6.00% | 89,502 | 99.00K |
| 381 | WVE | Wave Life Sciences Ltd. | 1.03B | 3.76% | 5,205,182 | 65.37M |
| 382 | JANX | Janux Therapeutics, Inc. | 1.02B | 0.91% | 652,780 | 24.00M |
| 383 | QDEL | QuidelOrtho Corporation | 1.02B | 6.00% | 1,953,334 | 2.67B |
| 384 | GERN | Geron Corporation | 1.01B | -3.68% | 10,200,647 | 204.56M |
| 385 | GMRS | GMR Solutions Inc. | 999.37M | 8.07% | 3,122,931 | 5.83B |
| 386 | OMER | Omeros Corporation | 992.27M | 0.81% | 3,583,213 | 38.42M |
| 387 | ARDX | Ardelyx, Inc. | 989.27M | 0.76% | 4,954,857 | 450.89M |
| 388 | SLDB | Solid Biosciences Inc. | 972.00M | 2.43% | 744,823 | - |
| 389 | CSTL | Castle Biosciences, Inc. | 960.17M | -2.51% | 418,197 | 357.28M |
| 390 | PCRX | Pacira BioSciences, Inc. | 944.73M | -2.79% | 760,017 | 746.16M |
| 391 | GLAS | Glass House Brands Inc. | 922.83M | 3.11% | 282,567 | 177.68M |
| 392 | DSGN | Design Therapeutics, Inc. | 917.45M | 0.27% | 396,759 | - |
| 393 | OLMA | Olema Pharmaceuticals, Inc. | 913.48M | 0.10% | 1,301,546 | - |
| 394 | ABUS | Arbutus Biopharma Corporation | 908.12M | -1.71% | 1,399,243 | 181.72M |
| 395 | KURA | Kura Oncology, Inc. | 882.42M | 0.10% | 1,146,385 | 77.23M |
| 396 | CBLL | CeriBell, Inc. | 879.24M | 7.51% | 532,635 | 101.96M |
| 397 | TBPH | Theravance Biopharma, Inc. | 878.47M | - | 513,790 | 104.31M |
| 398 | INMD | InMode Ltd. | 875.43M | 0.59% | 427,818 | 374.63M |
| 399 | ANNX | Annexon, Inc. | 873.28M | -0.19% | 3,950,316 | - |
| 400 | TALK | Talkspace, Inc. | 868.92M | - | 1,468,326 | 245.73M |
| 401 | AVR | Anteris Technologies Global Corp. | 864.43M | -3.27% | 832,923 | 2.24M |
| 402 | ACRS | Aclaris Therapeutics, Inc. | 859.64M | -1.35% | 937,107 | 8.22M |
| 403 | SIBN | SI-BONE, Inc. | 851.55M | 1.06% | 329,280 | 213.60M |
| 404 | AMPH | Amphastar Pharmaceuticals, Inc. | 849.91M | -2.15% | 347,535 | 730.02M |
| 405 | SGP | SpyGlass Pharma, Inc. | 845.23M | 1.69% | 76,848 | - |
| 406 | COLL | Collegium Pharmaceutical, Inc. | 836.68M | -1.08% | 1,123,202 | 808.21M |
| 407 | DBVT | DBV Technologies S.A. | 833.37M | 0.35% | 146,743 | 5.04M |
| 408 | HSTM | HealthStream, Inc. | 829.25M | - | 266,137 | 321.12M |
| 409 | CLYM | Climb Bio, Inc. | 826.51M | 3.90% | 1,318,634 | - |
| 410 | PHAR | Pharming Group N.V. | 820.19M | -3.27% | 38,281 | 366.48M |
| 411 | IMMX | Immix Biopharma, Inc. | 813.40M | -1.04% | 1,548,610 | - |
| 412 | AURA | Aura Biosciences, Inc. | 803.71M | -3.61% | 901,978 | - |
| 413 | OCS | Oculis Holding AG | 795.73M | 1.10% | 253,041 | 1.45M |
| 414 | EVO | Evotec SE | 789.86M | 4.29% | 49,367 | 859.03M |
| 415 | DRUG | Bright Minds Biosciences Inc. | 787.36M | -1.10% | 108,216 | - |
| 416 | CADL | Candel Therapeutics, Inc. | 782.53M | 0.28% | 1,378,941 | - |
| 417 | RIGL | Rigel Pharmaceuticals, Inc. | 782.13M | -0.36% | 336,450 | 276.79M |
| 418 | BBNX | Beta Bionics, Inc. | 779.67M | -1.65% | 637,846 | 119.01M |
| 419 | VREX | Varex Imaging Corporation | 777.63M | -0.70% | 2,248,720 | 865.00M |
| 420 | ATTO | Attovia Therapeutics, Inc. | 777.10M | -3.16% | 603,869 | 1.35M |
| 421 | MNPR | Monopar Therapeutics Inc. | 771.23M | 0.38% | 354,197 | - |
| 422 | AHCO | AdaptHealth Corp. | 769.77M | 2.12% | 4,282,044 | 3.36B |
| 423 | CTMX | CytomX Therapeutics, Inc. | 760.47M | 1.16% | 2,519,270 | 18.30M |
| 424 | FTH | Faeth Therapeutics, Inc. | 759.19M | -2.07% | 282,786 | - |
| 425 | PHR | Phreesia, Inc. | 757.81M | -0.08% | 450,599 | 495.59M |
| 426 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 754.61M | 2.39% | 150,523 | - |
| 427 | STTK | Shattuck Labs, Inc. | 751.72M | 4.32% | 1,286,907 | 1.00M |
| 428 | NGNE | Neurogene Inc. | 740.02M | 3.30% | 342,609 | 925.00K |
| 429 | SSII | SS Innovations International, Inc. | 738.49M | 2.22% | 17,440 | 48.47M |
| 430 | PHAT | Phathom Pharmaceuticals, Inc. | 728.37M | 7.76% | 2,084,115 | 239.66M |
| 431 | RGNX | REGENXBIO Inc. | 720.20M | 2.44% | 877,291 | 174.48M |
| 432 | TECX | Tectonic Therapeutic, Inc. | 720.00M | 15.56% | 665,542 | - |
| 433 | ALLO | Allogene Therapeutics, Inc. | 714.47M | -2.36% | 4,577,716 | 4.64M |
| 434 | IRWD | Ironwood Pharmaceuticals, Inc. | 713.84M | 0.47% | 2,720,705 | 389.32M |
| 435 | HELP | Cybin Inc. | 712.20M | 13.88% | 3,618,495 | - |
| 436 | GYRE | Gyre Therapeutics, Inc. | 706.18M | 0.30% | 94,545 | 109.82M |
| 437 | CBIO | Crescent Biopharma, Inc. | 703.22M | -1.56% | 214,714 | 11.88M |
| 438 | AGMB | AgomAb Therapeutics NV | 694.89M | -4.98% | 151,419 | - |
| 439 | ACHV | Achieve Life Sciences, Inc. | 688.42M | -1.18% | 1,407,580 | - |
| 440 | ZVRA | Zevra Therapeutics, Inc. | 679.35M | 0.88% | 718,264 | 136.07M |
| 441 | ANGO | AngioDynamics, Inc. | 650.99M | - | 787,417 | 320.17M |
| 442 | KIDS | OrthoPediatrics Corp. | 649.09M | 2.56% | 252,397 | 252.72M |
| 443 | SOPH | SOPHiA GENETICS SA | 644.42M | -0.53% | 409,988 | 86.17M |
| 444 | STLN | Starling Oncology, Inc. | 644.11M | 1.94% | 1,282,756 | 587.24M |
| 445 | SLN | Silence Therapeutics plc | 641.44M | -7.74% | 5,443,544 | 615.00K |
| 446 | NVCT | Nuvectis Pharma, Inc. | 636.64M | 0.70% | 78,744 | - |
| 447 | TLRY | Tilray Brands, Inc. | 634.68M | -2.09% | 2,971,246 | 915.45M |
| 448 | BWAY | BrainsWay Ltd. | 631.83M | 10.81% | 654,277 | 60.70M |
| 449 | VSTM | Verastem, Inc. | 629.42M | -1.42% | 1,263,817 | 87.53M |
| 450 | MDXG | MiMedx Group, Inc. | 623.85M | -0.93% | 728,676 | 355.17M |
| 451 | CTKB | Cytek Biosciences, Inc. | 621.32M | 0.84% | 846,427 | 206.71M |
| 452 | FDMT | 4D Molecular Therapeutics, Inc. | 620.52M | 3.49% | 428,879 | 88.24M |
| 453 | SPRY | ARS Pharmaceuticals, Inc. | 600.78M | 1.68% | 1,313,932 | 98.99M |
| 454 | CTEV | Claritev Corporation | 598.58M | 1.03% | 125,664 | 994.67M |
| 455 | DCTH | Delcath Systems, Inc. | 593.70M | -0.64% | 774,575 | 95.42M |
| 456 | PRLD | Prelude Therapeutics Incorporated | 590.16M | 7.71% | 623,877 | 22.42M |
| 457 | SGMT | Sagimet Biosciences Inc. | 583.67M | -1.37% | 1,096,359 | - |
| 458 | ARVN | Arvinas, Inc. | 579.98M | -1.33% | 524,410 | 316.70M |
| 459 | ALT | Altimmune, Inc. | 569.81M | -2.33% | 6,045,805 | 31.00K |
| 460 | PRME | Prime Medicine, Inc. | 569.29M | -1.84% | 1,443,942 | 4.07M |
| 461 | AUTL | Autolus Therapeutics plc | 564.22M | -9.01% | 4,059,386 | 117.39M |
| 462 | EIKN | Eikon Therapeutics, Inc. | 564.12M | 1.86% | 371,292 | - |
| 463 | ARTV | Artiva Biotherapeutics, Inc. | 563.70M | -2.12% | 275,055 | 251.00K |
| 464 | CTNM | Contineum Therapeutics, Inc. | 563.56M | 1.08% | 1,000,644 | - |
| 465 | CRMD | CorMedix Inc. | 557.01M | -2.74% | 1,353,419 | 400.05M |
| 466 | TCMD | Tactile Systems Technology, Inc. | 555.21M | 1.49% | 577,428 | 350.31M |
| 467 | ZURA | Zura Bio Limited | 553.89M | 3.96% | 1,219,041 | - |
| 468 | CERS | Cerus Corporation | 546.13M | 5.65% | 2,719,809 | 221.55M |
| 469 | VALN | Valneva SE | 538.47M | -0.72% | 76,043 | 180.25M |
| 470 | EOLS | Evolus, Inc. | 536.33M | -2.64% | 959,131 | 316.49M |
| 471 | SRTA | Strata Critical Medical, Inc. | 533.45M | - | 724,526 | 255.98M |
| 472 | AQST | Aquestive Therapeutics, Inc. | 530.91M | -4.08% | 9,116,267 | 54.09M |
| 473 | ANL | Adlai Nortye Ltd. | 523.60M | 0.08% | 125,315 | 5.00M |
| 474 | ASMB | Assembly Biosciences, Inc. | 520.93M | -0.77% | 113,071 | 71.10M |
| 475 | MPLT | MapLight Therapeutics, Inc. | 516.03M | -5.01% | 478,520 | - |
| 476 | FLGT | Fulgent Genetics, Inc. | 514.81M | -1.53% | 197,267 | 323.93M |
| 477 | EVMN | Evommune, Inc. | 512.44M | -0.63% | 694,559 | 10.00M |
| 478 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 479 | RLMD | Relmada Therapeutics, Inc. | 503.48M | 5.59% | 1,663,025 | - |
| 480 | NPCE | NeuroPace, Inc. | 499.76M | -3.26% | 186,192 | 106.99M |
| 481 | BLSM | BlossomHill Therapeutics, Inc. | 497.65M | -1.69% | 424,236 | - |
| 482 | OABI | OmniAb, Inc. | 497.24M | 1.18% | 793,421 | 38.46M |
| 483 | RZLT | Rezolute, Inc. | 490.99M | 1.73% | 2,391,286 | - |
| 484 | KYTX | Kyverna Therapeutics, Inc. | 489.40M | 0.37% | 1,031,422 | - |
| 485 | OVID | Ovid Therapeutics Inc. | 489.00M | 1.55% | 931,297 | 7.12M |
| 486 | DNA | Ginkgo Bioworks Holdings, Inc. | 485.52M | -3.99% | 1,064,655 | 132.42M |
| 487 | ENTX | Entera Bio Ltd. | 484.80M | -6.67% | 410,046 | 42.00K |
| 488 | BIOA | BioAge Labs, Inc. | 481.00M | -1.78% | 614,537 | 10.36M |
| 489 | CCCC | C4 Therapeutics, Inc. | 479.80M | 0.78% | 1,956,740 | 35.04M |
| 490 | PRTA | Prothena Corporation plc | 475.38M | 0.43% | 274,927 | 54.53M |
| 491 | OCGN | Ocugen, Inc. | 474.75M | 2.19% | 3,182,828 | 4.58M |
| 492 | EVH | Evolent Health, Inc. | 471.46M | 1.71% | 3,662,611 | 2.10B |
| 493 | CABA | Cabaletta Bio, Inc. | 464.71M | 2.15% | 2,806,524 | - |
| 494 | CLPT | ClearPoint Neuro, Inc. | 463.05M | 1.88% | 538,730 | 42.28M |
| 495 | PBYI | Puma Biotechnology, Inc. | 459.42M | 1.48% | 372,143 | 231.24M |
| 496 | QTTB | Q32 Bio Inc. | 457.56M | -0.26% | 270,075 | 53.74M |
| 497 | LRMR | Larimar Therapeutics, Inc. | 456.15M | 1.39% | 1,180,762 | - |
| 498 | SGHT | Sight Sciences, Inc. | 456.13M | 6.84% | 487,939 | 83.38M |
| 499 | NRC | NRC Health | 455.88M | -3.60% | 171,613 | 140.00M |
| 500 | PROK | ProKidney Corp. | 447.44M | -8.07% | 2,428,994 | 818.00K |